Oculus Innovative Sciences Introduces MicrocynAH® Next-Generation Dermatology Products with Dimethicone for Animals

PETALUMA, Calif. — (September 24, 2015) — Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) (tradable warrants OCLSW), a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care in both humans and animals, today announced the introduction of two new MicrocynAH® dermatology products for animals. MicrocynAH® Anti-Itch Spray Gel and [...]

Oculus Innovative Sciences Announces Launch of MicrocynAH® Farm and Ranch Animal Healthcare Products

Ten North American distributors have added MicrocynAH® animal healthcare products to their product portfolios since launch in February 2015 Antibiotic-free MicrocynAH® helps create an optimal wound healing environment without the use of antibiotics, better enabling farmers and ranchers to support President Obama’s five-year plan to fight the threat posed by antibiotic-resistant bacteria MicrocynAH® advanced animal [...]

Oculus Innovative Sciences Announces New Animal Healthcare Division and Launch of MicrocynAH® Advanced All-Animal Healthcare Products

New products include multiple Microcyn®-based all-animal wound and skin care liquids and hydrogels as well as all-animal ophthalmic gel Current launch in the United States and Canada is intended to be followed by summer expansion into Europe MicrocynAH® advanced animal healthcare products’ safety and efficacy profiles validated by two major animal healthcare studies and over [...]

Go to Top